[Complete atrio-ventricular block: a rare complication of interferon alpha therapy].
Nicolas-Charles
NC
Roche
Philippe
P
Paule
Sébastien
S
Kerebel
Jean-Marie
JM
Gil
Philippe
P
Heno
Laurent
L
Fourcade
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D054537:Atrioventricular Block / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D003299:Cooperative Behavior; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D033183:Interdisciplinary Communication; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D010138:Pacemaker, Artificial; D011092:Polyethylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D012815:Signal Processing, Computer-Assisted
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a